SCHEMBL26329006

SCHEMBL26329006

CC(C)[C@@H](C)Cc1ccncc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.47
CYP1A2 P05177 3/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 3/20 0.47
TRPA1 O75762 3/20 0.45
LOXL2 Q9Y4K0 2/20 0.44
SLC6A2 P23975 2/20 0.43
SLC6A3 Q01959 2/20 0.43
SLC6A4 P31645 1/20 0.43
ALDH1A1 P00352 4/20 0.42
CYP2D6 P10635 3/20 0.42
HSD17B10 Q99714 3/20 0.42
ALOX15 P16050 3/20 0.40
ALOX12 P18054 3/20 0.40
CYP19A1 P11511 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
ESR1 P03372 2/20 0.40
TP53 P04637 2/20 0.40
HPGD P15428 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21851278 1.00 CYP3A4 (0.47) CYP3A4CYP1A2CYP2C9CYP2C19TRPA1
SCHEMBL104529 0.82 CYP3A4 (0.48) CYP3A4CYP1A2CYP2C9CYP2C19LOXL2
SCHEMBL1678437 0.81 CYP2D6 (0.65) CYP3A4CYP1A2CYP2C9CYP2C19LOXL2
Ammonia Solution, Strong SCHEMBL29040632 0.80 CYP3A4 (0.47) CYP3A4CYP1A2CYP2C9CYP2C19LOXL2
Iodide SCHEMBL1750931 0.80 CYP2C9 (0.47) CYP3A4CYP1A2CYP2C9CYP2C19LOXL2
SCHEMBL19522791 0.79 CYP3A4 (0.47) CYP3A4CYP1A2CYP2C9CYP2C19TRPA1
SCHEMBL8513064 0.78 CYP3A4 (0.55) CYP3A4CYP1A2CYP2C9CYP2C19TRPA1
SCHEMBL16321985 0.78 TAAR1 (0.60) LOXL2SLC6A2SLC6A3SLC6A4
SCHEMBL11062127 0.78 CYP3A4 (0.45) CYP3A4CYP1A2CYP2C9CYP2C19LOXL2
SCHEMBL4662841 0.78 CYP3A4 (0.45) CYP3A4CYP1A2CYP2C9CYP2C19LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767302-B2 Reagents and methods for tetrazine synthesis UNIVERSITY OF DELAWARE (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767302-B2 Reagents and methods for tetrazine synthesis TST, CYP4F8, CYP4Z1 CYP3A4 29/4885CYP1A2 129/4885CYP2C9 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.